Search results
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
Motley Fool via Yahoo Finance· 2 hours agoProduct sales rose to $90 million in Europe during the first quarter. Without approval from the FDA,...
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 19 hours agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Novavax Inc (NVAX) (Q1 2024) Earnings Call Transcript Highlights: Strategic Partnerships and ...
GuruFocus.com via Yahoo Finance· 1 day agoThe company is still in the process of negotiating adjustments to dose volumes, pricing, and delivery schedules with several countries, which could affect revenue projections and market stability ...
Company News For May 13, 2024
Zacks via Yahoo Finance· 22 hours agoNovavax, Inc. (NVAX) shares surged 98.7% after announcing a $1.2 billion deal with Sanofi (SNY) to commercialize a combined COVID-19 and flu vaccine....
Novavax Starts A New Chapter, Turning The Page On Financial Uncertainty
RTT News· 1 day agoJust when the Covid-vaccine maker Novavax Inc.'s (NVAX) future as a going concern seemed uncertain, a remarkable turnaround has unfolded, thanks to the license deal with Sanofi ...
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 losses | Invezz
Invezz· 4 days agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven not only by the...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 4 days agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
Novavax stock soars 40% on Sanofi partnership By Investing.com
Investing.com· 4 days agoNovavax (NASDAQ:NVAX) shares rocketed 40% in premarket trading Friday, driven by the company’s...
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
FOX 23 News Albany· 4 days agoAnnounces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing ...
Novavax shares surge on new $1.4 billion deal with Sanofi
Market Watch· 4 days agoNovavax NVAX shares surged 45% in Friday’s pre-market trading session having lost 50% of their value...